S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Will I Be Able To Retire At All? Options Expert Weighs In (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
Holding NVDA? Read This Now (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Will I Be Able To Retire At All? Options Expert Weighs In (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
Holding NVDA? Read This Now (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Will I Be Able To Retire At All? Options Expert Weighs In (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
Holding NVDA? Read This Now (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
His system isolated NVIDIA - Here's His Next Buy. (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
Will I Be Able To Retire At All? Options Expert Weighs In (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
Holding NVDA? Read This Now (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
NYSE:DGX

Quest Diagnostics (DGX) Earnings Date, Estimates & Call Transcripts

$135.01
+0.89 (+0.66%)
(As of 08/11/2023 08:48 PM ET)
Compare
Today's Range
$133.56
▼
$135.09
50-Day Range
$133.15
▼
$145.01
52-Week Range
$120.40
▼
$158.34
Volume
665,200 shs
Average Volume
1.04 million shs
Market Capitalization
$15.15 billion
P/E Ratio
19.65
Dividend Yield
2.10%
Price Target
$149.90
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Oct. 19Estimated
Actual EPS
(Jul. 26)
$2.30 Beat By $0.07
Consensus EPS
(Jul. 26)
$2.23
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

DGX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DGX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Quest Diagnostics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20231$1.93$1.93$1.93 
Q2 20232$2.11$2.11$2.11 
Q3 20232$2.14$2.19$2.17 
Q4 20232$2.12$2.20$2.16 
FY 20237$8.30$8.43$8.37 
Q1 20242$2.10$2.11$2.11 
Q2 20242$1.74$2.35$2.05 
Q3 20242$2.28$2.46$2.37 
Q4 20242$2.32$2.36$2.34 
FY 20248$8.44$9.28$8.86 
Q1 20251$2.05$2.05$2.05 
Q2 20251$2.42$2.42$2.42 

DGX Earnings Date and Information

Quest Diagnostics last released its quarterly earnings results on July 26th, 2023. The medical research company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $0.07. The firm earned $2.34 billion during the quarter, compared to analysts' expectations of $2.25 billion. Its revenue for the quarter was down 4.7% on a year-over-year basis. Quest Diagnostics has generated $6.87 earnings per share over the last year ($6.87 diluted earnings per share) and currently has a price-to-earnings ratio of 19.7. Earnings for Quest Diagnostics are expected to grow by 4.02% in the coming year, from $8.70 to $9.05 per share. Quest Diagnostics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 19th, 2023 based off prior year's report dates.

Quest Diagnostics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
10/19/2023
Estimated)		------- 
7/26/2023Q2 2023$2.23$2.30+$0.07$2.55$2.25 billion$2.34 billion    
4/27/2023Q1 2023$1.97$2.04+$0.07$2.30$2.20 billion$2.33 billion      
2/2/2023Q4 2022$1.90$1.98+$0.08$3.09$2.26 billion$2.33 billion    
10/20/2022Q3 2022$2.17$2.36+$0.19$2.55$2.34 billion$2.49 billion      
7/21/2022Q2 2022$2.26$2.36+$0.10$2.76$2.34 billion$2.45 billion      
4/21/2022Q1 2022$2.91$3.22+$0.31$3.52$2.64 billion$2.61 billion    
2/3/2022Q4 2021$3.35$3.33($0.02)$3.54$2.66 billion$2.74 billion    
10/20/2021Q3 2021$2.88$3.96+$1.08$3.90$2.52 billion$2.77 billion    
7/22/2021Q2 2021$2.87$3.18+$0.31$1.40$2.38 billion$2.55 billion    
4/22/2021Q1 2021$3.77$3.76($0.01)$4.06$2.66 billion$2.72 billion  
2/4/2021Q4 2020$4.28$4.48+$0.20$4.75$2.92 billion$3.00 billion  
10/22/2020Q3 2020$3.75$4.31+$0.56$4.48$2.71 billion$2.79 billion    












Quest Diagnostics Earnings - Frequently Asked Questions

When is Quest Diagnostics's earnings date?

Quest Diagnostics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 19th, 2023 based off last year's report dates. Learn more on DGX's earnings history.

Did Quest Diagnostics beat their earnings estimates last quarter?

In the previous quarter, Quest Diagnostics (NYSE:DGX) reported $2.30 earnings per share (EPS) to beat the analysts' consensus estimate of $2.23 by $0.07. Learn more on analysts' earnings estimate vs. DGX's actual earnings.

How can I listen to Quest Diagnostics's earnings conference call?

The conference call for Quest Diagnostics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Quest Diagnostics's conference call transcript?

The conference call transcript for Quest Diagnostics's latest earnings report can be read online. Read Transcript

How much revenue does Quest Diagnostics generate each year?

Quest Diagnostics (NYSE:DGX) has a recorded annual revenue of $9.49 billion.

How much profit does Quest Diagnostics generate each year?

Quest Diagnostics (NYSE:DGX) has a recorded net income of $946 million. DGX has generated $6.87 earnings per share over the last four quarters.

What is Quest Diagnostics's price-to-earnings ratio?

Quest Diagnostics (NYSE:DGX) has a trailing price-to-earnings ratio of 19.65 and a forward price-to-earnings ratio of 15.52.

What is Quest Diagnostics's EPS forecast for next year?

Quest Diagnostics's earnings are expected to grow from $8.70 per share to $9.05 per share in the next year, which is a 4.02% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:DGX) was last updated on 8/14/2023 by MarketBeat.com Staff

My Account -